Inhibrx Historical Financial Ratios

INBX Stock

USD 14.97 0.04 0.27%

Inhibrx is lately reporting on over 99 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 43.23 or Days Sales Outstanding of 166 will help investors to properly organize and evaluate Inhibrx financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

About Inhibrx Financial Ratios Analysis

InhibrxFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Inhibrx investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Inhibrx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Inhibrx history.

Inhibrx Financial Ratios Chart

At this time, Inhibrx's Capex To Revenue is fairly stable compared to the past year. Cash Per Share is likely to rise to 6.19 in 2024, whereas Free Cash Flow Yield is likely to drop (0.12) in 2024.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Inhibrx stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Inhibrx sales, a figure that is much harder to manipulate than other Inhibrx multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Inhibrx dividend as a percentage of Inhibrx stock price. Inhibrx dividend yield is a measure of Inhibrx stock productivity, which can be interpreted as interest rate earned on an Inhibrx investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Inhibrx's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Inhibrx current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.At this time, Inhibrx's Capex To Revenue is fairly stable compared to the past year. Cash Per Share is likely to rise to 6.19 in 2024, whereas Free Cash Flow Yield is likely to drop (0.12) in 2024.

	2023	2024 (projected)
Dividend Yield	0.001705	0.002089
Price To Sales Ratio	994.97	1.0K

Dividend Yield Price To Sales Ratio

Inhibrx fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.18	0.65	0.97	0.33	-0.87	-0.91	0.69	0.65	1.0	-0.91	-0.29	-0.6	-0.86	-0.94	-0.49	0.97	0.76	0.69	0.31	0.52	0.13	0.68	0.96	-0.34	-0.95
Dividend Yield	-0.18		-0.78	-0.07	-0.12	0.53	0.51	-0.1	-0.78	-0.17	0.51	-0.28	0.8	0.59	0.15	0.85	-0.15	-0.52	-0.78	0.24	-0.92	0.29	-0.79	-0.27	0.84	0.42
Ptb Ratio	0.65	-0.78		0.58	0.3	-0.83	-0.86	0.6	1.0	0.64	-0.86	0.23	-0.9	-0.9	-0.62	-0.97	0.63	0.79	0.97	-0.01	0.92	-0.32	0.97	0.73	-0.9	-0.82
Days Sales Outstanding	0.97	-0.07	0.58		0.26	-0.76	-0.84	0.77	0.58	0.98	-0.84	-0.27	-0.47	-0.78	-0.97	-0.42	0.99	0.64	0.59	0.24	0.43	0.06	0.58	0.96	-0.27	-0.9
Book Value Per Share	0.33	-0.12	0.3	0.26		-0.41	-0.51	-0.06	0.3	0.32	-0.5	-0.62	-0.54	-0.48	-0.33	-0.17	0.22	0.71	0.34	0.42	0.19	0.58	0.31	0.35	-0.06	-0.48
Free Cash Flow Yield	-0.87	0.53	-0.83	-0.76	-0.41		0.96	-0.56	-0.83	-0.86	0.96	0.09	0.86	0.96	0.76	0.76	-0.79	-0.92	-0.92	-0.27	-0.76	-0.01	-0.91	-0.81	0.64	0.93
Operating Cash Flow Per Share	-0.91	0.51	-0.86	-0.84	-0.51	0.96		-0.6	-0.86	-0.91	1.0	0.2	0.86	0.99	0.85	0.74	-0.86	-0.93	-0.9	-0.26	-0.76	-0.07	-0.89	-0.92	0.6	0.99
Capex To Depreciation	0.69	-0.1	0.6	0.77	-0.06	-0.56	-0.6		0.6	0.7	-0.61	0.33	-0.27	-0.62	-0.79	-0.54	0.82	0.37	0.54	0.13	0.39	-0.55	0.56	0.7	-0.53	-0.65
Pb Ratio	0.65	-0.78	1.0	0.58	0.3	-0.83	-0.86	0.6		0.64	-0.86	0.23	-0.9	-0.9	-0.62	-0.97	0.63	0.79	0.97	-0.01	0.92	-0.32	0.97	0.73	-0.9	-0.82
Ev To Sales	1.0	-0.17	0.64	0.98	0.32	-0.86	-0.91	0.7	0.64		-0.91	-0.29	-0.59	-0.86	-0.94	-0.49	0.97	0.76	0.69	0.31	0.51	0.13	0.67	0.96	-0.33	-0.95
Free Cash Flow Per Share	-0.91	0.51	-0.86	-0.84	-0.5	0.96	1.0	-0.61	-0.86	-0.91		0.19	0.86	0.99	0.86	0.75	-0.86	-0.93	-0.9	-0.26	-0.76	-0.06	-0.89	-0.92	0.61	0.99
Roic	-0.29	-0.28	0.23	-0.27	-0.62	0.09	0.2	0.33	0.23	-0.29	0.19		0.08	0.11	0.26	-0.39	-0.18	-0.29	0.14	-0.29	0.17	-0.93	0.18	-0.26	-0.56	0.23
Inventory Turnover	-0.6	0.8	-0.9	-0.47	-0.54	0.86	0.86	-0.27	-0.9	-0.59	0.86	0.08		0.89	0.5	0.86	-0.5	-0.91	-0.94	-0.07	-0.89	-0.05	-0.93	-0.64	0.75	0.8
Net Income Per Share	-0.86	0.59	-0.9	-0.78	-0.48	0.96	0.99	-0.62	-0.9	-0.86	0.99	0.11	0.89		0.83	0.8	-0.83	-0.93	-0.94	-0.27	-0.82	0.03	-0.93	-0.86	0.7	0.97
Days Of Inventory On Hand	-0.94	0.15	-0.62	-0.97	-0.33	0.76	0.85	-0.79	-0.62	-0.94	0.86	0.26	0.5	0.83		0.47	-0.99	-0.68	-0.64	-0.34	-0.5	0.0	-0.63	-0.93	0.35	0.9
Payables Turnover	-0.49	0.85	-0.97	-0.42	-0.17	0.76	0.74	-0.54	-0.97	-0.49	0.75	-0.39	0.86	0.8	0.47		-0.49	-0.69	-0.94	0.12	-0.93	0.46	-0.95	-0.57	0.97	0.69
Capex To Revenue	0.97	-0.15	0.63	0.99	0.22	-0.79	-0.86	0.82	0.63	0.97	-0.86	-0.18	-0.5	-0.83	-0.99	-0.49		0.66	0.65	0.29	0.51	-0.04	0.65	0.94	-0.37	-0.91
Cash Per Share	0.76	-0.52	0.79	0.64	0.71	-0.92	-0.93	0.37	0.79	0.76	-0.93	-0.29	-0.91	-0.93	-0.68	-0.69	0.66		0.87	0.36	0.71	0.22	0.85	0.74	-0.56	-0.9
Pocfratio	0.69	-0.78	0.97	0.59	0.34	-0.92	-0.9	0.54	0.97	0.69	-0.9	0.14	-0.94	-0.94	-0.64	-0.94	0.65	0.87		0.09	0.93	-0.22	1.0	0.71	-0.87	-0.85
Interest Coverage	0.31	0.24	-0.01	0.24	0.42	-0.27	-0.26	0.13	-0.01	0.31	-0.26	-0.29	-0.07	-0.27	-0.34	0.12	0.29	0.36	0.09		-0.11	0.28	0.08	0.18	0.09	-0.28
Payout Ratio	0.52	-0.92	0.92	0.43	0.19	-0.76	-0.76	0.39	0.92	0.51	-0.76	0.17	-0.89	-0.82	-0.5	-0.93	0.51	0.71	0.93	-0.11		-0.26	0.93	0.59	-0.87	-0.7
Capex To Operating Cash Flow	0.13	0.29	-0.32	0.06	0.58	-0.01	-0.07	-0.55	-0.32	0.13	-0.06	-0.93	-0.05	0.03	0.0	0.46	-0.04	0.22	-0.22	0.28	-0.26		-0.26	0.09	0.61	-0.08
Pfcf Ratio	0.68	-0.79	0.97	0.58	0.31	-0.91	-0.89	0.56	0.97	0.67	-0.89	0.18	-0.93	-0.93	-0.63	-0.95	0.65	0.85	1.0	0.08	0.93	-0.26		0.7	-0.89	-0.84
Days Payables Outstanding	0.96	-0.27	0.73	0.96	0.35	-0.81	-0.92	0.7	0.73	0.96	-0.92	-0.26	-0.64	-0.86	-0.93	-0.57	0.94	0.74	0.71	0.18	0.59	0.09	0.7		-0.41	-0.95
Income Quality	-0.34	0.84	-0.9	-0.27	-0.06	0.64	0.6	-0.53	-0.9	-0.33	0.61	-0.56	0.75	0.7	0.35	0.97	-0.37	-0.56	-0.87	0.09	-0.87	0.61	-0.89	-0.41		0.54
Roe	-0.95	0.42	-0.82	-0.9	-0.48	0.93	0.99	-0.65	-0.82	-0.95	0.99	0.23	0.8	0.97	0.9	0.69	-0.91	-0.9	-0.85	-0.28	-0.7	-0.08	-0.84	-0.95	0.54

Click cells to compare fundamentals

Inhibrx Account Relationship Matchups

Inhibrx fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	82.93	65.03	232.97	453.75	994.97	1.0K
Ptb Ratio	(8.06)	11.04	31.69	17.02	41.17	43.23
Days Sales Outstanding	17.58	17.53	44.98	43.07	157.76	165.65
Book Value Per Share	(2.56)	2.99	1.38	1.45	0.92	0.97
Free Cash Flow Yield	(0.0439)	(0.0449)	(0.0592)	(0.0489)	(0.12)	(0.11)
Operating Cash Flow Per Share	(0.88)	(1.9)	(2.11)	(2.87)	(4.1)	(3.9)
Stock Based Compensation To Revenue	0.44	0.39	2.11	8.17	13.8	14.49
Capex To Depreciation	1.56	1.34	0.72	0.56	3.86	4.05
Pb Ratio	(8.06)	11.04	31.69	17.02	41.17	43.23
Ev To Sales	86.25	57.9	224.43	420.78	957.31	1.0K
Free Cash Flow Per Share	(0.93)	(1.95)	(2.14)	(2.89)	(4.2)	(3.99)
Roic	0.86	(0.6)	(0.61)	(0.49)	(0.87)	(0.82)
Inventory Turnover	14.94	(0.57)	(3.06)	(11.07)	(0.1)	(0.0976)
Net Income Per Share	(1.41)	(2.99)	(2.15)	(3.62)	(5.12)	(4.87)
Days Of Inventory On Hand	24.43	(642.04)	(119.22)	(32.96)	(3.6K)	(3.4K)
Payables Turnover	5.12	15.38	5.46	0.29	0.66	0.14
Sales General And Administrative To Revenue	0.99	0.53	1.73	9.7	16.32	17.14
Research And Ddevelopement To Revenue	5.27	5.74	10.03	50.59	106.47	111.79
Capex To Revenue	0.2	0.11	0.12	0.31	2.55	2.68
Cash Per Share	0.32	5.09	3.45	6.83	5.9	6.19
Pocfratio	(23.51)	(17.36)	(20.67)	(8.57)	(9.26)	(9.73)
Interest Coverage	(7.64)	(6.24)	(14.68)	(8.02)	(6.89)	(7.23)
Capex To Operating Cash Flow	(0.0564)	(0.0284)	(0.0108)	(0.00595)	(0.0238)	(0.0249)
Pfcf Ratio	(22.25)	(16.88)	(20.45)	(8.52)	(9.05)	(9.5)
Days Payables Outstanding	23.73	66.84	1.2K	556.99	2.5K	2.7K
Income Quality	0.62	0.63	0.98	0.79	0.8	1.05
Roe	0.55	(1.0)	(1.56)	(2.5)	(5.55)	(5.27)
Ev To Operating Cash Flow	(24.45)	(15.46)	(19.91)	(7.95)	(8.91)	(9.36)
Pe Ratio	(14.67)	(11.01)	(20.3)	(6.8)	(7.42)	(7.79)
Return On Tangible Assets	(1.94)	(0.53)	(0.54)	(0.5)	(0.78)	(0.82)
Ev To Free Cash Flow	(23.14)	(15.03)	(19.7)	(7.9)	(8.71)	(9.14)
Earnings Yield	(0.0682)	(0.0908)	(0.0493)	(0.15)	(0.13)	(0.14)
Net Debt To E B I T D A	(0.71)	1.35	0.79	0.57	0.33	0.21
Current Ratio	0.76	4.21	6.2	10.17	5.25	3.26
Tangible Book Value Per Share	(2.56)	2.99	1.38	1.45	0.92	0.97
Receivables Turnover	20.76	20.83	8.12	8.47	2.31	2.2
Graham Number	9.0	14.19	8.17	10.86	10.31	6.5
Shareholders Equity Per Share	(2.56)	2.99	1.38	1.45	0.92	0.97
Debt To Equity	(0.45)	0.5	1.38	3.51	4.8	5.05
Capex Per Share	0.0495	0.054	0.0227	0.0171	0.0975	0.1

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Inhibrx Historical Financial Ratios

About Inhibrx Financial Ratios Analysis

Inhibrx Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ev To Sales

Inhibrx fundamentals Correlations

Inhibrx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inhibrx fundamentals Accounts

Also Currently Popular

Additional Tools for Inhibrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Capex To Revenue	+ 0.99	Days Sales Outstanding
Net Income Per Share	+ 0.99	Operating Cash Flow Per Share

Capex To Revenue	- 0.99	Days Of Inventory On Hand
Payables Turnover	- 0.97	Pb Ratio
Days Of Inventory On Hand	- 0.97	Days Sales Outstanding
Payables Turnover	- 0.97	Ptb Ratio
Roe	- 0.95	Days Payables Outstanding
Pfcf Ratio	- 0.95	Payables Turnover